NCT06374485View on ClinicalTrials.gov

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

December 28, 2025

Study Completion Date

December 31, 2025

Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG

AU409

Oral administration

Trial Locations (1)

Unknown

RECRUITING

Department of Clinical Oncology, Queen Mary Hospital, Hong Kong

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY